6:10am ET
Investing
The 6 Most Shorted Nasdaq Stocks: Short Sellers Pile on Apple
Short sellers piled on to Apple again between the November 13 and November 30 settlement dates, lifting its short interest to a year-to-date high.
Companies
Mylan Inc.
$15.86
â–² $0.00 (+0.00%) today
Markets open · 1:38pm ET
MYL Coverage
Page 7
1:05pm ET
Health and Healthcare
What Perrigo and Teva Can Learn From Mylan’s Share Repurchase
Mylan announced Monday that it would be conducting a share repurchase for up to $1 billion, in a much faster timeline for repurchasing than most companies would give.
7:03am ET
Investing
The 6 Most Shorted Nasdaq Stocks: Short Sellers Shy Away From Apple
Between the October 15 and October 30 settlement dates, short interest declined in many of the most heavily shorted stocks traded on the Nasdaq.
8:45am ET
Health and Healthcare
Is Mylan’s Topline Growth Enough for Investors?
Mylan reported better-than-expected third-quarter financial results before the markets opened on Friday.
Chris Lange 1:05pm ET
Health and Healthcare
What to Expect From Mylan Earnings
Mylan is scheduled to release its third-quarter financial results before the markets open on Friday.
Chris Lange 7:05am ET
Health and Healthcare
Generics Giants Like Teva and Mylan May Now Join the Buy-and-Raise Craze
Martin Shkreli has said he would lower the price of Daraprim back down but hasn’t actually done it. He probably figures that if he can outlast the initial wave of negative publicity,…
1:55pm ET
Health and Healthcare
Mylan Fires Back at Perrigo
Mylan announced Tuesday, in conjunction with the Irish Takeover Panel, that Perrigo had made misleading statements to shareholders.
8:20am ET
Health and Healthcare
Big Catalysts Coming Within a Week for 2 Specialty Pharmaceutical Stocks
ThinkstockWith biotech and specialty pharmaceutical stocks, catalysts and binary events can drive the stocks much higher, or in some cases much lower if the outcome is not what Wall Street was looking…
7:35am ET
Health and Healthcare
5 Top BioPharma Stocks That May Have Sold Off Too Much and Become Bargains
It may be impossible to ever know if a true bottom has ever been seen, but many investors love finding great companies where they feel that a sell-off has overly punished the…
10:35am ET
Health and Healthcare
UBS Makes Big Changes to Quality Growth at a Reasonable Price Portfolio
A new research report from UBS makes an interesting switch in the Quality Growth At a Reasonable Price (Q-GARP) portfolio.
2:34pm ET
Health and Healthcare
Key Analyst Sees Mylan as a Value Play
ThinkstockMylan N.V. (NASDAQ: MYL) is considered a serious value play in the health care sector by a key analyst. Argus has a Buy rating for the company but reduced its price target…
Chris Lange 8:50am ET
Investing
Top Analyst Upgrades and Downgrades: BankUnited, Barrick Gold, ConocoPhillips, Michael Kors, Mylan, Viacom, Disney and Many More
Friday's top analyst upgrades, downgrades and initiations include BankUnited, Barrick Gold, ConocoPhillips, Michael Kors, Mylan, Viacom and Disney.
9:15am ET
Investing
The 7 Most Important Earnings in the Week Ahead
Frank Golhen, via Wikimedia Commons24/7 Wall St. has put together a preview of some of the major companies reporting their quarterly results this week. We have included the consensus earnings estimates from…
1:44pm ET
Health and Healthcare
Teva Proves Its Decade-Hold Status With Massive Funding
ThinkstockTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) may have just proved how financially fit and capable the company is. On Friday afternoon the global generic drug giant reported that it has secured financing…
7:20am ET
Health and Healthcare
Why Teva Pharmaceutical Bid for Mylan May Go Hostile
Teva could be about to enter the largest generic market by prescription in the world, which may tip the scales in its favor when it comes to wooing Mylan shareholders.